Skip to main content
SpringerLink
Log in

Methadone Programmes

The Costs and Benefits to Society and the Individual

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cherubin CE. The medical sequelae of narcotic addiction. Ann Intern Med 1967: 67: 23–33

    PubMed  CAS  Google Scholar 

  2. Prayurahong B, Pongpaew P, Migasenan P, et al. B vitamin status: effect of prolonged heroin addiction and methadonetreatment. J Med Asoc Thai 1991: 74: 131–4

    CAS  Google Scholar 

  3. Gambara SE, Clark JK. Comments on dietary intake of drug dependent person. J Am Diet Assoc 1976: 68: 155–7

    Google Scholar 

  4. Aylett A. Some aspects of nutritional state in ‘hard’ drug addicts. Brit J Addict 1978: 73: 77–81

    Article  CAS  Google Scholar 

  5. Heathcote J, Taylor KB. Immunity and nutrition in heroin addicts. Drug Alcohol Depend 1981: 8: 245–56

    Article  PubMed  CAS  Google Scholar 

  6. Nakah A, Frank O, Louria BB, et al. Vitamin profile of heroin addiction. Am J Public Health 1979: 69: 1058–60

    Article  PubMed  Google Scholar 

  7. Zolopa AR, Hahn J A. HIV and tuberculosis infection in San Francisco’s homeless adults: prevalence and risk factors in arepresentative sample. JAMA 1994: 272: 455–61

    Article  PubMed  CAS  Google Scholar 

  8. Hughes S, Caverley PMA. Heroin inhalation and asthma. BMJ 1988; 297: 1511–12

    Article  PubMed  CAS  Google Scholar 

  9. Lam SK, To WK, Duthie SJ, et al. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust NZ J Obstet Gynaecol 1992; 32: 216–21

    Article  CAS  Google Scholar 

  10. Hussey HH, Katz S. Infections resulting from narcotic addiction. Am J Med 1950; 9: 186–93

    Article  PubMed  CAS  Google Scholar 

  11. Hussey HH, Keliher TF, Schaefer BF, et al. Septicaemia and bacterial endocarditis resulting from heroin addiction. JAMA 1944; 126: 535–40

    Article  Google Scholar 

  12. Mientjes GHC, Miedema F, van Ameijden EJ, et al. Frequent injecting impairs lymphocyte reactivity in HIV—positive and HIV—negative drug users. AIDS 1991; 5: 35–41

    Article  PubMed  CAS  Google Scholar 

  13. Welch GH, Reid DB, Pollock JG. Infected false aneurysms in the groin of intravenous drug abusers. Br J Surg 1990; 77: 330–3

    Article  PubMed  CAS  Google Scholar 

  14. Van den Hoek JAR, van Haastrecht HJA, Goudsmit J, et al. Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162: 823–6

    Article  PubMed  Google Scholar 

  15. Woodfield DG, Hamess M, Rix-Trott K. Hepatitis C virus infection in oral and injectable drug users. N Z Med J 1993; 106: 332–4

    PubMed  CAS  Google Scholar 

  16. Crofts N, Hopper JL, Bowden DS, et al. Hepatitis C virus infection among cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237–41

    PubMed  CAS  Google Scholar 

  17. Fingerhood MI, Jasinski DR, Sullivan JT. Prevalence of hepatitis B in a chemically dependent population. Arch Intern Med 1993; 159: 237–41

    Google Scholar 

  18. Baumgarten R. Correlation between disease and community: is drug addiction a problem of fringe groups? Forensic Sci Int 1993; 62: 67–72

    Article  PubMed  CAS  Google Scholar 

  19. Corty E, Ball JC, Myers CP. Psychological symptoms in methadone maintenance patients: prevalence in change overtreatment. J Consult Clin Psychol 1988; 56: 776–7

    Article  PubMed  CAS  Google Scholar 

  20. Darke S, Wodak A, Hall W, et al. Prevalence and predictors of psychopathology among opioid users. Br J Addict 1992; 87: 771–6

    Article  PubMed  CAS  Google Scholar 

  21. Steer RA, Iguchi MY, Platt JJ. Use of the revised Beck Depression Inventory with intravenous drug users not in treatment. Psychol Addict Behav 1992; 6: 225–32

    Article  Google Scholar 

  22. Swift W, Williams G, Neill O, et al. The prevalence of minor psychopathology in opioid users seeking treatment. Br J Addict 1990; 85: 629–34

    Article  PubMed  CAS  Google Scholar 

  23. Brooner RK, Greenfield L, Schmidt CW, et al. Antisocial personality disorder and HIV infection in drug abusers. Am J Psychiatry 1993; 150: 53

    PubMed  CAS  Google Scholar 

  24. Darke S, Hall W, Ross M, Wodak A. Benzodiazepine use and HIV risk—taking behaviour among injecting drug users. Drug Alcohol Depend 1992; 31: 31–6

    Article  PubMed  CAS  Google Scholar 

  25. Inchiardi JA. Heroin use and street crime. Crime Delinq 1979; 25: 335–46

    Article  Google Scholar 

  26. Hammersley R, Forsyth A, Lavelle T. A criminality of new drug users in Glasgow. Br J Addict 1990; 85: 1583–94

    Article  PubMed  CAS  Google Scholar 

  27. Spunt BJ. The link between identity and crime for the heroin addict in methadone treatment. Int J Addict 1993; 28: 813–25

    PubMed  CAS  Google Scholar 

  28. Dobinson I, Ward P. Drugs and crime. Bureau of Crime Statistics and Research. Sydney Attorney General’s Department. 1985

    Google Scholar 

  29. Bell J, Hall W, Byth K. Changes in criminal activity after entering methadone maintenance. Br J Addict 1992; 87: 251–8

    Article  PubMed  CAS  Google Scholar 

  30. Taylor PL, Albright Jr WJ. Non—drug criminal behaviour and heroin use. Int J Addict 1981; 16: 683–96

    PubMed  CAS  Google Scholar 

  31. Maddux JF, Desmond DP. Heroin addicts and their nonaddicted brothers. Am J Drug Alcohol Abuse 1984; 10: 237–48

    Article  PubMed  CAS  Google Scholar 

  32. Casado-Flores J, Bano-Rodrig A, Romero E. Social and medical problems in children of heroin addicted parents: a study of 75 patients. Am J Dis Child 1990; 144: 977–9

    PubMed  CAS  Google Scholar 

  33. Heather N. Disulfiram treatment for alcohol problems: is it effective and. if so why? In: Brewer C. editor. Treatment optionsin addiction. London: Gaskell. 1993; 1–18

    Google Scholar 

  34. Marlatt GA, Gordon JR. Relapse prevention. New York: Guildford Press. 1985

    Google Scholar 

  35. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer Verlag. 1991

    Book  Google Scholar 

  36. Wilson P, Watson R, Ralston GE. Methadone maintenance in general practice: patients, workload and outcomes. BMJ 1994; 309: 641–4

    Article  PubMed  CAS  Google Scholar 

  37. Capelhom JR, Bell J, Kleinbaum DJ, et al. Methadone and heroin use during methadone maintenance treatment. Addiction 1993; 88: 119–24

    Article  Google Scholar 

  38. Ward J, Mattick RP, Hall W. Key issues in methadone maintenance treatment. Sydney: New South Wales University Press.

  39. Dole VP, Joseph HJ. Methadone maintenance: outcome after termination. N Y State J Med 1977; 77: 1409–12

    PubMed  CAS  Google Scholar 

  40. Bellius DJ. Reductiun of AIDS risk among 41 heroin addicted female street prostitutes: effects of free methadone maintenance. J Addict Dis 1993; 12: 7–23

    Article  Google Scholar 

  41. Reno RR, Aitken LS. Life activities and life quality of heroin addicts in and out of methadone treatment. Int J Addict 1993; 28: 211–32

    PubMed  CAS  Google Scholar 

  42. Binchey JM, Molyneaux EM, Manning J. Accidental ingestion of methadone by children in Merseyside. BMJ 1994; 304: 1335–6

    Article  Google Scholar 

  43. Maddux JF, Desmond DP. Methadone maintenance and recovery from opioid dependence. Am J Drug Alcohol Abuse 1992; 18: 63–74

    Article  PubMed  CAS  Google Scholar 

  44. Plotnick RD. Applying benefit cost analysis to substance use prevention programmes. Int J Addict 1994; 29: 339–59

    PubMed  CAS  Google Scholar 

  45. Tolley K, Rowland N. Evaluating the cost—effectiveness of counselling in health care. London: Routledge. 1994

    Google Scholar 

  46. Yates BT. Cost—effectiveness and cost-benefit analysis: an introduction. Behav Assess 1985; 7: 207–34

    Article  Google Scholar 

  47. Yates BT. Toward the incorporation of costs, cost—effectiveness analysis, and cost—benefit analysis into clinical research. J Consult Clin Psychol 1994; 4: 729–36

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Psychology, Community and Mental Health Unit Trust, Stobhill Hospital, G21 3UW, Balornock, Glasgow, Scotland

    George E. Ralston

  2. Glasgow University Department of General Practice, Woodside Health Centre, Glasgow, Scotland

    Philip Wilson

Authors
  1. George E. Ralston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ralston, G.E., Wilson, P. Methadone Programmes. Pharmacoeconomics 10, 321–326 (1996). https://doi.org/10.2165/00019053-199610040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199610040-00002

Keywords

Search

Navigation